New dual targeting approach for combating hormone receptor positive breast cancer

Alternate Hormone Therapy Approaches for Invasive Estrogen Receptor-Positive Breast CancerПодробнее

Dr. Bardia on Dual Targeting of the HER2 ReceptorПодробнее

Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment OptionsПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Treatment approach for metastatic HER2 positive breast cancerПодробнее

Current and future HER2+, HR- metastatic breast cancer treatment approachesПодробнее

First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast CancerПодробнее

2nd line treatment options for HR+ breast cancer.Подробнее

Role of chemotherapy in early hormone receptor-positive breast cancerПодробнее

Discover hormone-positive breast cancer and its treatment options 🎗️💊Подробнее

Anti-Estrogen Therapy and Breast Cancer RecurrenceПодробнее

Targeted Therapies in Breast Cancer TreatmentПодробнее

Dr. Amengual on Dual Targeting With an HDAC 6 Inhibitor and Bortezomib in LymphomaПодробнее

What I Tell My Patients: Hormonal Therapy for Hormone Receptor-Positive Breast CancerПодробнее

Elle Macpherson blasted for ‘holistic’ breast cancer treatment approachПодробнее

Changing landscape in the management of HER2 positive locally advanced and metastatic breast cancerПодробнее

Ask the expert: Hormone receptor-positive breast cancerПодробнее

Background on Capivasertib - now approved for breast cancerПодробнее

Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment StrategiesПодробнее